PPCB Earnings — Propanc Biopharma, Inc. Common Stock Post-ER Performance | BigEarnings
PPCB — Propanc Biopharma, Inc. Common Stock
XNAS · Healthcare · Biotechnology
Price$1.15
Market Cap$4.0M
P/E—
52W Range$0.95 – $77.48
Next Earnings2026-09-15
About Propanc Biopharma, Inc. Common Stock
Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.
